Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
COLLCollegium Pharmaceutical(COLL) Zacks Investment Research·2024-05-10 07:01

For the quarter ended March 2024, Collegium Pharmaceutical (COLL) reported revenue of 144.92million,up0.1144.92 million, up 0.1% over the same period last year. EPS came in at 1.45, compared to 1.32intheyear−agoquarter.ThereportedrevenuecomparestotheZacksConsensusEstimateof1.32 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of 147.04 million, representing a surprise of -1.44%. The company delivered an EPS surprise of -2.68%, with the consensus EPS estimate being $1.49. While investors closely watch year-over-year changes in headline numbers -- revenue and earni ...